Ashland Inc (ASH) Q4 2025 Earnings Call Highlights: Navigating Challenges with Strategic Growth ...

Despite an 8% sales decline, Ashland Inc (ASH) maintained strong margins and achieved strategic gains in Life Sciences and ...
TipRanks on MSN

Oncopeptides’ NK Cell Engager Study to be Presented at ASH

The latest update is out from Oncopeptides AB ( (SE:ONCO) ).
TipRanks on MSN

BioInvent to Present Promising BI-1808 Data at ASH 2025

BioInvent International AB ( ($SE:BINV) ) just unveiled an update. BioInvent International AB announced the presentation of updated Phase 2a data ...

Geron Corporation Reports Third Quarter 2025 Financial Results and Recent Business Highlights

Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course ...
TMCnet

Cogent Biosciences Reports Recent Business Highlights and Third Quarter 2025 Financial Results

WALTHAM, Mass. and BOULDER, Colo., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined ...